KPTI News and Press, Karyopharm Therapeutics Inc. From 02/28/20

NEWTON, Mass., Feb. 28, 2020 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced the appointment of Richard Paulson to its Board of Directors. Mr. Paulson is currently Executive Vice President and Chief Executive Office...

Cancer-drug maker Karyopharm Therapeutics (NASDAQ: KPTI) has seen phenomenal growth since early 2019, with its stock up more than 60% in a bit more than a year. The 12-year-old company is pioneering novel drugs that will help treat patients with certain blood cancers or solid tumors. Over t...

Under Priority Review status, the FDA accepts Karyopharm Therapeutics' (NASDAQ: KPTI ) supplemental marketing application seeking approval to use Xpovio (selinexor) to treat adults with relapsed/refractory diffuse large B-cell lymphoma who have received at least two prior therapies. More...

NEWTON, Mass., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its supplemental New Drug Application (sNDA) seeking accelerated ...

NEWTON, Mass., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced that Michael Kauffman, MD, PhD, Chief Executive Officer, will participate in a fireside chat at the 9 th Annual SVB Leerink Global Health...

Don't let schooling interfere with your education ."- Mark Twain Busted IPO Forum model portfolio holding Karyopharm Therapeutics ( KPTI ) reported Q4 results late this week. This report shows the company continues to make impressive progress with its initial rollout with recently appro...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Image source: The Motley Fool. Karyopharm Therapeutics Inc   (NASDAQ: KPTI) Q4 2019 Earnings Call Feb 13, 2020 , 8:30 a.m. ET Operator Continue reading

Karyopharm Therapeutics Inc. (KPTI) Q4 2019 Earnings Conference Call February 12, 2020 8:30 AM ET Company Participants Ian Karp - Vice President, Investor and Public Relations Michael Kauffman - Chief Executive Officer Mike Mason - Chief Financial Officer Perry Monaco - Senior ...

The following slide deck was published by Karyopharm Therapeutics Inc. in conjunction with their 2019 Q4 earnings Read more ...